SCHEMBL25461666

SCHEMBL25461666

c1cc(-c2cccc3oc4cccnc4c23)c2nccnc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.40
MAPT P10636 5/20 0.40
ALDH1A1 P00352 4/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
USP2 O75604 1/20 0.40
POLB P06746 1/20 0.40
TP53 P04637 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 2/20 0.34
ALOX15 P16050 2/20 0.34
HTT P42858 2/20 0.34
GMNN O75496 1/20 0.34
HSP90AA1 P07900 1/20 0.34
MMP2 P08253 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MMP9 P14780 1/20 0.34
TSHR P16473 1/20 0.34
NFKB1 P19838 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25461665 0.95 KDM4E (0.35) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL25461250 0.83 KDM4E (0.50) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL25523906 0.79 MAPT (0.50) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL3069598 0.78 KDM4E (0.58) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL18232956 0.77 TOP1 (0.42) KDM4EMAPTALDH1A1TP53SMN1; SMN2
SCHEMBL18159577 0.76 MAPT (0.39) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL25461669 0.76 LMNA (0.38) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL25461667 0.75 KDM4E (0.37) KDM4EMAPTALDH1A1TP53SMN1; SMN2
SCHEMBL25461251 0.75 RAB9A (0.48) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL25461429 0.74 KDM4E (0.43) KDM4EMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, EHD1 KDM4E 2555/4885MAPT 2164/4885ALDH1A1 686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.